J. Jakubczak

发表

Potentiation of oncolytic adenoviral vector efficacy with gutless vectors encoding GMCSF or TRAIL

K. Burroughs, D. Kayda, K. Sakhuja, 2004, Cancer Gene Therapy.

Transgenic Mice Overexpressing a Dominant-negative Mutant Type II Transforming Growth Factor β Receptor Show Enhanced Tumorigenesis in the Mammary Gland and Lung in Response to the Carcinogen 7,12-Dimethylbenz-[a]-anthracene

L. Wakefield, E. Bottinger, J. Jakubczak, 1997 .

Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancer

Ying Huang, P. Ryan, J. Jakubczak, 2004, Cancer Gene Therapy.

Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene.

L. Wakefield, J. Jakubczak, E. Böttinger, 1997, Cancer research.

Phase I, open-label, multicentre, dose-escalation, pharmacokinetic and pharmacodynamic trial of the oral aurora kinase inhibitor PF-03814735 in advanced solid tumours.

Suzanne F. Jones, H. Burris, J. Infante, 2011, European journal of cancer.

Transgenic Mice Overexpressing a Dominant-negative Mutant Type II Transforming Growth Factor ÃŸReceptor Show Enhanced Tumorigenesis in the Mammary Gland and Lung in Response to the Carcinogen

J. Jakubczak, D. Haines, M. Wakefield, 2006 .

Ribosomal DNA insertion elements R1Bm and R2Bm can transpose in a sequence specific manner to locations outside the 28S genes.

T. Eickbush, J. Jakubczak, W. Burke, 1988, Nucleic acids research.

Disassociation of Met-Mediated Biological Responses In Vivo: the Natural Hepatocyte Growth Factor/Scatter Factor Splice Variant NK2 Antagonizes Growth but Facilitates Metastasis

G. Merlino, T. Otsuka, J. Jakubczak, 2000, Molecular and Cellular Biology.

NK1, a Natural Splice Variant of Hepatocyte Growth Factor/Scatter Factor, Is a Partial Agonist In Vivo

G. Merlino, J. Jakubczak, W. Larochelle, 1998, Molecular and Cellular Biology.

Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target.

J. French, G. Merlino, W. Muller, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Sequence relationship of retrotransposable elements R1 and R2 within and between divergent insect species.

T. Eickbush, J. Jakubczak, D. Eickbush, 1993, Molecular biology and evolution.

Turnover of R1 (type I) and R2 (type II) retrotransposable elements in the ribosomal DNA of Drosophila melanogaster.

T. Eickbush, J. Jakubczak, R. C. Woodruff, 1992, Genetics.

Increased Susceptibility to N‐Nitrosomethylurea Gastric Carcinogenesis in Transforming Growth Factor α Transgenic Mice with Gastric Hyperplasia

J. Ward, G. Merlino, J. Jakubczak, 1995, Japanese journal of cancer research : Gann.

Synergy between transforming growth factor alpha and hepatitis B virus surface antigen in hepatocellular proliferation and carcinogenesis.

F. Chisari, G. Merlino, J. Jakubczak, 1997, Cancer research.

PF-03814735, an Orally Bioavailable Small Molecule Aurora Kinase Inhibitor for Cancer Therapy

L. Pustilnik, J. Christensen, B. D. Cohen, 2010, Molecular Cancer Therapeutics.

Retrotransposable elements R1 and R2 interrupt the rRNA genes of most insects.

T. Eickbush, J. Jakubczak, W. Burke, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Enhanced Gene Transfer to Rabbit Jugular Veins by an Adenovirus Containing a Cyclic RGD Motif in the HI Loop of the Fiber Knob

J. Jakubczak, P. Hallenbeck, S. Stevenson, 2001, Journal of Vascular Research.

Type I (R1) and type II (R2) ribosomal DNA insertions of Drosophila melanogaster are retrotransposable elements closely related to those of Bombyx mori.

T. Eickbush, J. Jakubczak, Y. Xiong, 1990, Journal of molecular biology.

Design of selective, ATP-competitive inhibitors of Akt.

Tracey Clark, Matthew Marx, Blaise Lippa, 2010, Journal of medicinal chemistry.

Reverse transcription of R2Bm RNA is primed by a nick at the chromosomal target site: A mechanism for non-LTR retrotransposition

T. Eickbush, J. Jakubczak, D. Luan, 1993, Cell.

Genetic instability favoring transversions associated with ErbB2-induced mammary tumorigenesis

G. Merlino, K. Tindall, W. Muller, 2002, Proceedings of the National Academy of Sciences of the United States of America.

An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.

Ying Huang, P. Ryan, J. Jakubczak, 2003, Cancer research.

Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin.

C. Schnell, J. Jakubczak, P. Hallenbeck, 2000, Human gene therapy.

Preclinical Analysis of the γ-Secretase Inhibitor PF-03084014 in Combination with Glucocorticoids in T-cell Acute Lymphoblastic Leukemia

A. Ferrando, C. Cordon-Cardo, M. Castillo-Martin, 2012, Molecular Cancer Therapeutics.

Preclinical Development Preclinical Analysis of the g-Secretase Inhibitor PF-03084014 in Combination with Glucocorticoids in T-cell Acute Lymphoblastic Leukemia

A. Ferrando, C. Cordon-Cardo, M. Castillo-Martin, 2012 .

Expression of a dominant‐negative mutant TGF‐β type II receptor in transgenic mice reveals essential roles for TGF‐β in regulation of growth and differentiation in the exocrine pancreas

L. Wakefield, G. Merlino, J. Jakubczak, 1997 .

Adenovirus Type 5 Viral Particles Pseudotyped with Mutagenized Fiber Proteins Show Diminished Infectivity of Coxsackie B-Adenovirus Receptor-Bearing Cells

G. Nemerow, M. Rollence, J. Jakubczak, 2001, Journal of Virology.

ON THE CAUSES OF MONOPHAGY IN DROSOPHILA QUINARIA

A. C. James, J. Jakubczak, J. Jaenike, 1988, Evolution; international journal of organic evolution.

Phase I accelerated dose-escalation, pharmacokinetic (PK) and pharmacodynamic study of PF-03814735, an oral aurora kinase inhibitor, in patients with advanced solid tumors: Preliminary results

Suzanne F. Jones, H. Burris, J. Infante, 2008 .

Effects of donor source on transcriptomic profiles of human kidney tissue

J. Jakubczak, Richard Virgen-Slane, Seda Arat, 2023, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

282 POSTER Preliminary results of a Phase I accelerated dose-escalation, pharmacokinetic and pharmacodynamic study of PF-03814735, an oral Aurora kinase A and B inhibitor, in patients with advanced solid tumors

Suzanne F. Jones, H. Burris, J. Infante, 2008 .